Description Ionix Pharmaceuticals is charged up and ready to go. Ionix specializes in the research and development of analgesics (medicines used to treat pain). The company combines novel drug delivery systems with proprietary drug targets to create pharmaceuticals that treat pain resulting from arthritis, diabetes, surgery, and trauma. Lead candidate IX-1003 is being developed to treat acute post-operative pain. Ionix is also researching medicines to treat pain resulting from peripheral nervous system disorders. Business partners include Reckitt Benckiser Healthcare and Germany's Max Delbrück Center for Molecular Medicine. The company was founded in 2001.